← Back to headlines
Ozempic's Canadian Patent Questioned as Generics Emerge
The Canadian patent for the weight loss drug Ozempic is being questioned as generic versions are reportedly set to enter the market.
22 May, 10:00 — 22 May, 10:00
Sources
Showing 1 of 1 sources
Related Stories
Hungary’s Paks Nuclear Plant Returns to Full Power Output Ahead of Schedule
18m ago
Jennifer Garner Reveals Career Anxiety and Financial Fears Following Divorce
27m ago
Nigerian Government and Student Union Criticize Atiku’s Push to Restore Fuel Subsidies
48m ago
Meta Agrees to $18 Billion Settlement in Child Social Media Addiction Lawsuits
54m ago